Croos-Dabrera R - Search Results

1

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.

Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, Niki Y, Watanabe S, Furue M, Ito T, Croos-Dabrera R, Tack KJ. Kohno S, et al. Among authors: croos dabrera r. J Antimicrob Chemother. 2007 Dec;60(6):1361-9. doi: 10.1093/jac/dkm369. Epub 2007 Oct 3. J Antimicrob Chemother. 2007. PMID: 17913720 Clinical Trial.

2

Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.

Wilcox MH, Tack KJ, Bouza E, Herr DL, Ruf BR, Ijzerman MM, Croos-Dabrera RV, Kunkel MJ, Knirsch C. Wilcox MH, et al. Among authors: croos dabrera rv. Clin Infect Dis. 2009 Jan 15;48(2):203-12. doi: 10.1086/595686. Clin Infect Dis. 2009. PMID: 19072714 Clinical Trial.

3

Linezolid for the treatment of infections caused by Gram-positive pathogens in China.

Lin DF, Zhang YY, Wu JF, Wang F, Zheng JC, Miao JZ, Zheng LY, Sheng RY, Zhou X, Shen HH, Ijzerman MM, Croos-Dabrera RV, Sheng W. Lin DF, et al. Among authors: croos dabrera rv. Int J Antimicrob Agents. 2008 Sep;32(3):241-9. doi: 10.1016/j.ijantimicag.2008.04.004. Epub 2008 Jul 16. Int J Antimicrob Agents. 2008. PMID: 18635341 Clinical Trial.

4

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Wunderink RG, et al. Chest. 2003 Nov;124(5):1789-97. Chest. 2003. PMID: 14605050

5

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.

Kollef MH, Rello J, Cammarata SK, Croos-Dabrera RV, Wunderink RG. Kollef MH, et al. Intensive Care Med. 2004 Mar;30(3):388-94. doi: 10.1007/s00134-003-2088-1. Epub 2004 Jan 9. Intensive Care Med. 2004. PMID: 14714107

6

Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.

Kontoyiannis DP, Selleslag D, Mullane K, Cornely OA, Hope W, Lortholary O, Croos-Dabrera R, Lademacher C, Engelhardt M, Patterson TF. Kontoyiannis DP, et al. Among authors: croos dabrera r. J Antimicrob Chemother. 2018 Mar 1;73(3):757-763. doi: 10.1093/jac/dkx423. J Antimicrob Chemother. 2018. PMID: 29194488 Clinical Trial.

7

Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.

Marty FM, Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Oren I, Schmitt-Hoffmann AH, Giladi M, Rahav G, Perfect JR. Marty FM, et al. Among authors: croos dabrera r. Mycoses. 2018 Jul;61(7):485-497. doi: 10.1111/myc.12777. Epub 2018 Apr 26. Mycoses. 2018. PMID: 29611227 Clinical Trial.

8

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.

Perfect JR, Cornely OA, Heep M, Ostrosky-Zeichner L, Mullane KM, Maher R, Croos-Dabrera R, Lademacher C, Engelhardt M, Chen C, Marty FM. Perfect JR, et al. Among authors: croos dabrera r. Mycoses. 2018 Jul;61(7):420-429. doi: 10.1111/myc.12769. Epub 2018 Apr 19. Mycoses. 2018. PMID: 29570857 Free PMC article. Review.

9

Isavuconazole for treatment of rare invasive fungal diseases.

Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G. Cornely OA, et al. Among authors: croos dabrera r. Mycoses. 2018 Aug;61(8):518-533. doi: 10.1111/myc.12778. Mycoses. 2018. PMID: 29611246 Clinical Trial.

10

Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.

Thompson GR 3rd, Garcia-Diaz J, Miceli MH, Nguyen MH, Ostrosky-Zeichner L, Young JH, Fisher CE, Clark NM, Greenberg RN, Spec A, Kovanda L, Croos-Dabrera R, Kontoyiannis DP. Thompson GR 3rd, et al. Among authors: croos dabrera r. Mycoses. 2022 Feb;65(2):186-198. doi: 10.1111/myc.13412. Epub 2021 Dec 22. Mycoses. 2022. PMID: 34888961

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page